Literature DB >> 19673311

Ozonation of propranolol: formation of oxidation products.

Jessica Benner1, Thomas A Ternes.   

Abstract

Major oxidation products (OPs) of the beta blocker propranolol, formed during ozonation in aqueous solution were identified and oxidation pathways were proposed. Ozonation led to a high number of OPs being formed. In total, chemical structures were elucidated for five different nominal masses (including constitutional isomers, approximately 13 signals), whereas at least eight other OPs and their isomers (approximately 30 signals) remained unidentified. The structural elucidation was performed via liquid chromatography coupled with hybride triple quadrupole with linear ion trap (LC-Qq LIT MS). The primary ozonation product OP-291, was formed by ozone attacking the naphthalene ring, which resulted in the ring-opening and two aldehyde moieties being formed. OP-291 was further oxidized to OP-307, which was then oxidized to OP-281. Experiments were performed at pH 3 and pH 8, as well as in the presence and absence of a radical scavenger. Ozonation of wastewater treatment plant (WWTP) effluents spiked with propranolol (10 microM) led to the same OPs being formed as observed in the experiments with deionized water. Therefore, ozonation of WWTP effluent is resulting in the formation of a high number of OPs with an elevated toxic potential (i.e., formation of aldehydes).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673311     DOI: 10.1021/es900282c

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  8 in total

1.  Effectivity of advanced wastewater treatment: reduction of in vitro endocrine activity and mutagenicity but not of in vivo reproductive toxicity.

Authors:  Sabrina Giebner; Sina Ostermann; Susanne Straskraba; Matthias Oetken; Jörg Oehlmann; Martin Wagner
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-06       Impact factor: 4.223

2.  The key role of biogenic manganese oxides in enhanced removal of highly recalcitrant 1,2,4-triazole from bio-treated chemical industrial wastewater.

Authors:  Ruiqin Wu; Haobo Wu; Xinbai Jiang; Jinyou Shen; Muhammad Faheem; Xiuyun Sun; Jiansheng Li; Weiqing Han; Lianjun Wang; Xiaodong Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-10       Impact factor: 4.223

3.  Structural elucidation of main ozonation products of the artificial sweeteners cyclamate and acesulfame.

Authors:  Marco Scheurer; Markus Godejohann; Arne Wick; Oliver Happel; Thomas A Ternes; Heinz-Jürgen Brauch; Wolfgang K L Ruck; Frank Thomas Lange
Journal:  Environ Sci Pollut Res Int       Date:  2011-10-01       Impact factor: 4.223

4.  Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective.

Authors:  Stefan Gartiser; Christoph Hafner; Kerstin Kronenberger-Schäfer; Oliver Happel; Christoph Trautwein; Klaus Kümmerer
Journal:  Environ Sci Pollut Res Int       Date:  2012-05-01       Impact factor: 4.223

5.  Catalytic dechlorination of diclofenac by biogenic palladium in a microbial electrolysis cell.

Authors:  Bart De Gusseme; Maarten Soetaert; Tom Hennebel; Lynn Vanhaecke; Nico Boon; Willy Verstraete
Journal:  Microb Biotechnol       Date:  2012-01-06       Impact factor: 5.813

6.  Kinetic and mechanistic investigations of the degradation of propranolol in heat activated persulfate process.

Authors:  Yu-Qiong Gao; Jia-Nan Fang; Nai-Yun Gao; Xue-Nong Yi; Wei Mao; Jia Zhang
Journal:  RSC Adv       Date:  2018-12-10       Impact factor: 4.036

7.  Identification and structural elucidation of ozonation transformation products of estrone.

Authors:  Pedro Alejandro Segura; Pearl Kaplan; Viviane Yargeau
Journal:  Chem Cent J       Date:  2013-04-23       Impact factor: 4.215

8.  Quantitative analysis of 3-isopropylamino-1,2-propanediol as a degradation product of metoprolol in pharmaceutical dosage forms by HILIC-CAD.

Authors:  Qun Xu; Shane Tan
Journal:  J Pharm Anal       Date:  2019-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.